# Tamoxifen Citrate

NDC: 0378-0144
Generic name: Tamoxifen Citrate
Labeler / Manufacturer: Mylan Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20030220

FDA application: ANDA074732

## Active ingredients

- TAMOXIFEN CITRATE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0378-0144"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0378-0144
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0